
ROHTO PHARM CO by Rohto Pharmaceutical rose 13.2% from $15.19 to $17.20, ahead of the S&P 500's +3.2%. Its worst day was Mar 4 (−12.0%), and its low came Mar 4 at $14.34.
Nov 24, 2025 – Oct 5, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ROHTO PHARM CO by Rohto Pharmaceutical closed at its lowest level of the year, 5.6% below where the year started.
−12.0%, the year's worst day · S&P 500 +0.7%
Where it ended: a close of $17.20 on Oct 5, 2026.
Nothing in the past 12 months.
All RPHCF earningsStory events cover the past 12 months · Times ET
Nothing in the past 12 months.
All RPHCF analyst actionsNothing in the past 12 months.
All RPHCF dividend historyNothing in the past 12 months.
All RPHCF news